首页 正文

Identification and characterization of trametinib degradation product employing Orbitrap LC-HRMS, and development of a robust, eco-friendly stability indicating method of analysis

{{output}}
Trametinib is a selective MEK1/2 inhibitor approved for the treatment of various cancers. Stress testing of a drug is essential for understanding the stability profile and ensuring compliance with regulatory requirements during pharmaceutical development. To t... ...